Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.

Part of paid clinical trials in Sacramento, California.

Sponsor
Integrative Skin Science and Research
Study ID
NCT07560618
Phase
PHASE4
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
12 Years - N/A
Healthy Volunteers
Not accepted

Interventions

Study Details

This study is being done to obtain descriptive classifications of pruritus using a patient directed survey system and assess change in pruritus over time in patients with Atopic Dermatitis over 4 weeks with use of topical Roflumilast cream 0.15% QD.

Key Dates

First listed
May 1, 2026
Start date
Jul 21, 2026
Status verified
Aug 2026
Primary completion
Aug 31, 2027
Completion
Aug 31, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Roflumilast Group

Primary Outcome Measure

Number of descriptors (besides itch) used to describe skin sensations associated with AD [ Time Frame: From enrollment to end of treatment at 4 weeks. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Integrative Skin Science and ResearchSacramentoCalifornia95815
Nasima Afzal
[email protected]
9165241216
Raja Sivamani, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Sacramento, CA

Nationwide
Atopic dermatitis / eczema trialsDermatology trialsRheumatology trialsAutoimmune disease trials
By condition
Atopic dermatitis / eczema
By specialty
DermatologyRheumatologyAutoimmune disease
By research site
Integrative Skin Science and Research· Sacramento, CA

Related Studies